WASHINGTON (AP) — Federal regulators are expected to authorize the mixing and matching of COVID-19 booster shots  this week in an effort to provide flexibility for those seeking to maintain protection against the coronavirus .

Johnson & Johnson

Coronavirus

San Francisco, California

San Francisco

CBS Local

Associated Press News

abc 7 News 

foxtv.com

US expected to authorize mix-and-match COVID booster shots

-Johnson & Johnson on Tuesday raised its annual adjusted profit forecast, but kept the sales outlook for its COVID-19 vaccine at $2.5 billion for this year. Shares rose 1.4% as the drugmaker's third-quarter profit beat Wall Street expectations and it lifted 2021 forecast for adjusted earnings per share to between $9.77 and $9.82, from its prior estimates of $9.60 to $9.70. The

Business

US & Canada

Money

Vaccines

Yahoo News

Reuters

abc News

RTÉ

J&J raises 2021 profit view, keeps vaccine sales outlook unchanged

Virgin Galactic shares on Monday edged lower by 1.50% after UBS downgraded to sell from neutral citing delays in a scheduled test flight.

Virgin Galactic

Invezz

Johnson & Johnson CFO defends sales miss in fiscal Q3

Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 9.70% and -1.21%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for...

Zacks Investment Research

Johnson & Johnson (JNJ) Q3 Earnings Beat Estimates

Earnings season continues on Tuesday with major reports from Johnson & Johnson, Procter & Gamble, Netflix and United Airlines.

Procter & Gamble

Netflix

CNBC

Money Control.com

Stock futures are flat ahead of major earnings reports on Tuesday

U.S. stocks rallied Tuesday as earnings reports continued to exceed estimates.

Walmart

Fox Business

Stocks rally as J&J boosts outlook, Walmart gets Goldman lift

The stocks making the biggest moves in premarket trading include Procter & Gamble, Johnson & Johnson, Travelers and more.

Travel

Stock markets

Stocks making the biggest moves in the premarket: Procter & Gamble, Johnson & Johnson, Travelers and more

Recently, a U.S. advisory panel unanimously endorsed booster shots of the Johnson & Johnson COVID-19 vaccine for adults over the age of 18. The move comes as vaccines and public health protocols in the United States remain politically charged issues. VOA’s Arash Arabasadi reports. 
Produced by:  Arash Arabasadi

Johnson & Johnson

Stay current with the most up to date news on Johnson & Johnson with news from hundreds of news sources

TRENDING NOW

LATEST STORIES

Get the weekly blindspot report right in your inbox and stay up to date with your bias blindspot.

EXPLORE MORE CURRENT TOPICS

Subscribe and get full access to Ground News

EXPERIENCE